ArticleEClinicalMedicine2023

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial.

Prasanna Jagannathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.